Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |